{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04006",
    "Peptide Name": "Rombocin K (synthetic AMPs, UCSS1b)",
    "Source": "Amino acid substitution, bacteria-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "ITSISLCTAGCKTGVIMTCMSNGCK",
    "Sequence Length": 25,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 2,
    "Boman Index": 0,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "48%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Peptide design: A change I15 to K increased peptide activity.Sequence analysis: APD analysis reveals that this sequence is similar (96%) toRombocin AActivity:  active against L. lactis MG1363 (MIC 0.78 ug/ml), L. monocytogenes LMG10470 or TT82E or LK132 (MIC 6.25-12.5 ug/ml), B. cereus CH-85 (MIC 25 ug/ml), S. aureus LMG10147 or LMG15975 MRSA (MIC 100 ug/ml), and E. faecium LMG11423 or LMG16003 or LMG16216 (MIC 50 ug/ml) anti-VRE. Est.Jan2024;",
    "Author": "Guo L, Wambui J, Wang C, Broos J, Stephan R, Kuipers OP. 2024",
    "Reference": "ACS Synth Biol. 2024 Jan 9. doi: 10.1021/acssynbio.3c00612.PubMed",
    "Title": "Rombocin, a Short Stable Natural Nisin Variant, Displays Selective Antimicrobial Activity against Listeria monocytogenes and Employs a Dual Mode of Action to Kill Target Bacterial Strains."
  },
  "3D Structure": []
}